Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 99, 620-626
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (2012/03798-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (470119/2004-7)
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do HC-FMRP-USP (FAEPA) (1291/97, 355/2000, 68/2001, 15/2003)
- Pro-Rectory of the University of São Paulo (USP) Research
This publication has 35 references indexed in Scilit:
- 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal grayNeuropharmacology, 2011
- Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetineInternational Journal of Neuropsychopharmacology, 2009
- Panic Disorder: Is the PAG Involved?Neural Plasticity, 2009
- Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: Evidence from the elevated T-mazeNeuropharmacology, 2007
- Functional and ultrastructural neuroanatomy of interactive intratectal/tectonigral mesencephalic opioid inhibitory links and nigrotectal GABAergic pathways: Involvement of GABAA and μ1-opioid receptors in the modulation of panic-like reactions elicited by electrical stimulation of the dorsal midbrainJournal of Chemical Neuroanatomy, 2005
- Modeling panic attacksNeuroscience & Biobehavioral Reviews, 2001
- Synergistic μ-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neuronsNeuropharmacology, 2001
- Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrainBrain Research, 1999
- Anxiogenic stimuli in the elevated plus-mazePharmacology Biochemistry and Behavior, 1993
- 5-HT and mechanisms of defenceJournal of Psychopharmacology, 1991